Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors

January 2017 in “ Chemical & Pharmaceutical Bulletin ”

Wiranpat Karnsomwan, Ponsawan Netcharoensirisuk, Thanyada Rungrotmongkol, Wanchai De-Eknamkul, Supakarn Chamni

Avicequinone C Steroid 5α-Reductase 5α-reductase inhibitors HaCaT cells furanonaphthoquinones propionic substituent androgenic disorders alopecia 5-alpha-reductase inhibitors human skin cell line hair loss

TLDR Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

In 2016, a study was conducted to evaluate Avicequinone C analogues as potential inhibitors of Steroid 5α-Reductase, an enzyme linked to hair loss and alopecia. Several compounds were synthesized and their inhibitory effects were tested on HaCaT cells, a human skin cell line. The most potent compound, 5e, showed 22-fold more inhibitory activity compared to the original compound, Avicequinone C. The study concluded that furanonaphthoquinones, especially those with a propionic substituent, could potentially serve as new 5α-reductase inhibitors, offering a potential treatment for androgenic disorders like alopecia. However, further studies were recommended to understand the inhibitory mechanism.

View this study on jstage.jst.go.jp →

Discuss this study in the Community →

Cited in this study

13 / 13 results

research Androgenetic Alopecia: An Update Of Treatment Options

110 citations , August 2016 in “Drugs”

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

research In Silico Structural Prediction of Human Steroid 5α-Reductase Type II

3 citations , March 2016 in “Medicinal Chemistry Research”

Scientists found out the structure of a human enzyme linked to prostate cancer and hair loss, which could help in designing drugs.

research Identification of a New Plant Extract for Androgenic Alopecia Treatment Using a Non-Radioactive Human Hair Dermal Papilla Cell-Based Assay

17 citations , December 2015 in “BMC Complementary and Alternative Medicine”

A new plant extract from Avicennia marina could potentially be used to treat common hair loss.

research Potential Targets in the Discovery of New Hair Growth Promoters for Androgenic Alopecia

59 citations , June 2014 in “Expert Opinion on Therapeutic Targets”

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

research Avicequinone C Isolated from Avicennia Marina Exhibits 5α-Reductase Type 1 Inhibitory Activity Using an Androgenic Alopecia Relevant Cell-Based Assay System

19 citations , May 2014 in “Molecules”

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

research A Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia

97 citations , March 2014 in “Journal of The American Academy of Dermatology”

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

research The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases

218 citations , January 2012 in “Advances in Urology”

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

research Discovery of a Novel Hybrid from Finasteride and Epristeride as 5α-Reductase Inhibitor

18 citations , January 2011 in “Bioorganic & Medicinal Chemistry Letters”

New hybrid compound found to effectively prevent hair loss.

research Efficacy and Safety of Finasteride Therapy for Androgenetic Alopecia

152 citations , October 2010 in “Archives of Dermatology”

Finasteride helps hair growth but may cause sexual side effects.

research Efficacy, Safety, and Tolerability of Dutasteride 0.5 mg Once Daily in Male Patients with Male Pattern Hair Loss: A Randomized, Double-Blind, Placebo-Controlled, Phase III Study

92 citations , August 2010 in “Journal of The American Academy of Dermatology”

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

research Inhibition of 5α-Reductase Activity in SZ95 Sebocytes and HaCaT Keratinocytes In Vitro

24 citations , February 2007 in “Hormone and metabolic research”

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

research The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

215 citations , December 2006 in “Journal of The American Academy of Dermatology”

Dutasteride more effective for hair growth, but has more side effects than finasteride.

research Clinical Pharmacokinetics and Pharmacodynamics of Finasteride

93 citations , January 1996 in “Clinical Pharmacokinectics”

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

1 / 1 results

research Synthesis, Biological Evaluation and Molecular Docking of Avicequinone C Analogues as Potential Steroid 5α-Reductase Inhibitors

13 citations , January 2017 in “Chemical & Pharmaceutical Bulletin”

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.